Redcliffe Labs, a diagnostic network, to raise $200 million from PE investors

6 Jul 2022 , 09:15 AM

Redcliffe Labs, a chain of diagnostic centres, announced that it has started the process of finding $200 million in private equity funding. By the end of this year, the company hopes to have finished the fundraising.

With participation from Healthquad, Schroders, LC Nueva, Growth Spark Ventures, and current investors Chiratae Ventures and Alkemi Venture Partners, Redcliffe reported in May that it had secured $61 million as part of a series B led by LeapFrog Investments (LeapFrog).

Providing low-cost but high-quality direct-to-consumer (D2C) blood tests into tier 2, 3, and 4 towns and cities, as well as scaling up Redcliffe’s platform and expanding its product offerings to radiology, disease data profiling, and lifestyle management, will be accomplished with the investment.